Current laboratory tests for diagnosis of hepatitis B virus infection

Jong-Han Lee1, Hyon-Suk Kim2

  • 1Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.

Insights

Diagnosing Hepatitis B virus (HBV) infection relies on serologic and molecular methods. New biomarkers like HBcrAg and HBV RNA show promise for monitoring infection and guiding treatment, but require validation.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis B virus (HBV) infection poses a chronic health risk, potentially leading to cancer.
  • While vaccination has reduced HBV incidence, it remains a significant global health concern.

Purpose of the Study:

  • To review current diagnostic methods for HBV infection.
  • To explore future perspectives in HBV diagnosis and management.

Main Methods:

  • Comprehensive review of existing laboratory diagnostic techniques for HBV.
  • Analysis of current clinical practices in HBV diagnosis.

Main Results:

  • Established serologic and molecular assays are used for diagnosing acute and chronic HBV.
  • Intrahepatic covalently closed circular DNAs (cccDNAs) limit the cure of chronic HBV infection.
  • Emerging biomarkers, including hepatitis B virus core-related antigen (HBcrAg) and HBV RNA, correlate with cccDNA activity but need clinical validation.

Conclusions:

  • Effective HBV diagnosis and monitoring of treatment response are crucial for disease management.
  • Development of ultrasensitive immunologic assays may enhance HBV management alongside immunotherapy.
Abstract